Compounds, compositions and methods comprising oxadiazole derivatives
US8796321B2 · kind B2 · utility
5Cited by
60References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2012 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Jun 18, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-2 or encompassed by formulas I-IV) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.